JW (Cayman) Therapeutics Co. Ltd (JWCTF)
USD 0.17
(0.0%)
USD 0.17
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -655.74 Million CNY | 37.03% |
| 2022 | -752.27 Million CNY | -7.37% |
| 2021 | -700.47 Million CNY | 56.29% |
| 2020 | -1.6 Billion CNY | -409.87% |
| 2019 | -314.33 Million CNY | -106.72% |
| 2018 | -152.05 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -14.09 Million USD | 0.0% |
| 2024 Q1 | -14.19 Million USD | 69.03% |
| 2023 Q4 | -30.22 Million USD | -95.75% |
| 2023 FY | - CNY | 37.03% |
| 2023 Q3 | -15.44 Million USD | 59.23% |
| 2023 Q2 | -37.87 Million USD | -94.67% |
| 2023 Q1 | -19.45 Million USD | 58.66% |
| 2022 Q4 | -47.05 Million USD | -106.79% |
| 2022 FY | - CNY | -7.37% |
| 2022 Q2 | -47.27 Million USD | 0.0% |
| 2022 Q3 | -22.75 Million USD | 51.86% |
| 2021 Q4 | -64.32 Million USD | 0.0% |
| 2021 Q2 | -49.6 Million USD | 0.0% |
| 2021 FY | - CNY | 56.29% |
| 2020 Q4 | -38.07 Million USD | 0.0% |
| 2020 FY | - CNY | -409.87% |
| 2020 Q2 | -21.72 Million USD | 0.0% |
| 2019 FY | - CNY | -106.72% |
| 2019 Q4 | -16.97 Million USD | 0.0% |
| 2019 Q2 | -10.78 Million USD | 0.0% |
| 2018 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | -823.119% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -10960.163% |
| SQZ Biotechnologies Company | -64.14 Million USD | -922.352% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -3675.17% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 797.32% |
| Mesoblast Limited | -62.38 Million USD | -951.049% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -42590.5% |
| Genus plc | 73.7 Million USD | 989.752% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -9818.253% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -18387.38% |
| Marizyme, Inc. | -34.28 Million USD | -1812.832% |
| ContraFect Corporation | -64.99 Million USD | -908.857% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -7375.456% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -14387.82% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -46678.66% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -24697.122% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -28118.494% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -126480.844% |
| Accustem Sciences Inc. | -3.74 Million USD | -17403.301% |
| RVL Pharmaceuticals plc | -48.22 Million USD | -1259.709% |
| EV Biologics, Inc. | -1.26 Million USD | -51650.489% |
| Q BioMed Inc. | -617.62 Thousand USD | -106071.838% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 18457.979% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -103590.825% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -28604.319% |
| Biomind Labs Inc. | -1.03 Million USD | -63284.818% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 6739.131% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -9056.847% |
| Skye Bioscience, Inc. | -13.54 Million USD | -4740.336% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -43986.44% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -2622888.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -16781.9% |
| IMV Inc. | -35.52 Million USD | -1745.958% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -4032.06% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -26109.311% |
| GB Sciences, Inc. | -1.41 Million USD | -46083.106% |
| Alpha Cognition Inc. | -9.7 Million USD | -6656.377% |
| HST Global, Inc. | -5303.00 USD | -12365485.518% |
| CSL Limited | 4.78 Billion USD | 113.693% |
| Halberd Corporation | -74.27 Thousand USD | -882716.139% |
| Enzolytics Inc. | -2.12 Million USD | -30801.887% |
| Resverlogix Corp. | -11.74 Million USD | -5484.628% |
| Affymax, Inc. | -14.29 Million USD | -4487.248% |
| SYBLEU INC | -141.57 Thousand USD | -463093.027% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -21308.54% |
| argenx SE | -216.02 Million USD | -203.554% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | -1084.964% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 53982.251% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -43648.374% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 173191.563% |
| AVAX Technologies, Inc. | -6.11 Million USD | -10627.716% |
| Zenith Capital Corp. | -8.6 Million USD | -7519.649% |
| Genscript Biotech Corporation | -248.71 Million USD | -163.649% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -3764018.018% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -26703.902% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -372431.961% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -1554.387% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -22571.96% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -62572.224% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 9752434.92% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -37371.279% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -34037.292% |
| BioStem Technologies, Inc. | -7.55 Million USD | -8581.2% |
| ONE Bio Corp. | 13.61 Million USD | 4917.049% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -362015.104% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -31778.804% |
| Agentix Corp. | -1.37 Million USD | -47703.472% |
| LadRx Corporation | 412.28 Thousand USD | 159152.641% |
| Cell Source, Inc. | -4.27 Million USD | -15247.993% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -178470.125% |
| Regen BioPharma, Inc. | 1.46 Million USD | 44831.697% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -69887.481% |
| NovAccess Global Inc. | -1.03 Million USD | -63269.627% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 7506.39% |
| Itoco Inc. | -1.86 Million USD | -34985.541% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -172637.738% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -58658.692% |
| Kadimastem Ltd | -2.62 Million USD | -24886.73% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -274099.038% |
| CytoDyn Inc. | -18.02 Million USD | -3537.179% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -829654.9% |
| Mobile Lads Corp. | -2.24 Million USD | -29159.281% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -5362129.127% |
| Qrons Inc. | -40.08 Thousand USD | -1635954.49% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -134916.822% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 124428.019% |
| Rebus Holdings, Inc. | -951 Thousand USD | -68853.417% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -61645.84% |
| International Stem Cell Corporation | 202 Thousand USD | 324727.228% |
| Bioxytran, Inc. | -3.82 Million USD | -17065.491% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -1245619.985% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -26535.464% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -1728.172% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -1457115.556% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -23849.854% |
| Neutra Corp. | -181.24 Thousand USD | -361697.437% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -3152.875% |
| PureTech Health plc | -11.62 Million USD | -5539.864% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -3153.098% |
| IXICO plc | -707 Thousand USD | -92650.636% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -8432.817% |
| Gelesis Holdings, Inc. | -48.34 Million USD | -1256.362% |
| CSL Limited | 4.73 Billion USD | 113.855% |
| Cellectis S.A. | -92.63 Million USD | -607.875% |